Login Sign Up Contact Us

Categories

Countries

Request/Offer Detail

Title: Anti-ERBB2 (Trastuzumab)-VC-DUBA ADC
TypeName: Business Offer
Country: United States
Summary: https://www.creative-biolabs.com/adc/target-erbb2-37.htm This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a VC linker to DUBA. Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
Description: https://www.creative-biolabs.com/adc/target-erbb2-37.htm This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a VC linker to DUBA. Peptide linkers, belonging to Enzymatically cleavable linkers, combine greater systemic stability with rapid enzymatic release of the drug in the target cell. The scission of peptidic bonds relies on lysosomal proteolytic enzymes, which have very low activities in blood due to endogenous inhibitors and the unfavorably high pH value of blood.
Advantages:
Comments:
RequestId: 920
Name:Creative Biolabs
Telphone:
Email:marketing@creative-biolabs.com

Special Business
Desk Cycle
Sanor Insurance Agency,Inc.
Flyers Direct
Penny Appeal Australia

Sponsors
smartportal sponsors